The New Times (Kigali)
12 May 2008
It has been reported that Apotex Inc., Canada's largest pharmaceutical company will soon ship to Rwanda a new HIV/Aids drug. Apo-TriAvir combines Zidovudine, Lamivudine and Nevirapine, three drugs otherwise administered separately to patients.
[ See Article ]
